ASPIRE BIOPHARMA HOLDINGS, INC. Adjustments to Additional Paid in Capital, Other
ASPIRE BIOPHARMA HOLDINGS, INC. (ASBP) reported Adjustments to Additional Paid in Capital, Other of $10.81 million for the 12-month period ending 2023-12-31, per its 10-K filed 2025-04-07.
Financial Statements › Shareholders' Equity
us-gaap:AdjustmentsToAdditionalPaidInCapitalOther · last filed 2025-04-07
- ASPIRE BIOPHARMA HOLDINGS, INC. adjustments to additional paid in capital, other for the quarter ending 2023-06-30 was $10.81M.
- ASPIRE BIOPHARMA HOLDINGS, INC. adjustments to additional paid in capital, other for fiscal 2023 was $10.81M.
| Period end | Adjustments to Additional Paid in Capital, Other 3 month | Adjustments to Additional Paid in Capital, Other 12 month |
|---|---|---|
| 2023-12-31 | $10.81M 10-K · filed 2025-04-07 | |
| 2023-06-30 | $10.81M 10-Q · filed 2024-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B |